Climb Bio, Inc. (CLYM)
Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.
Address
20 WILLIAM STREET
WELLESLEY HILLS, MA 02481
Founded
2018
Number of Employees
9
Website
http://www.climbbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at CLYM make a trade.
Creating a free account takes less than one minute